Effect of cell determinant (CD)34+ cell dose on the cost and consequences of peripheral blood stem cell transplantation for non-Hodgkin's lymphoma patients in front-line therapy.

Limat, S; Woronoff-Lemsi, M C; Milpied, N; Chartrin, I; Ifrah, N; Deconinck, E; Gressin, R; Colombat, P; Cahn, J Y; Arveux, P

Limat, S; Woronoff-Lemsi, M C; Milpied, N; Chartrin, I; Ifrah, N; Deconinck, E; Gressin, R; Colombat, P; Cahn, J Y; Arveux, P.

Affiliation

Limat S; Department of Pharmacy, Besançon University Hospital, France.

Eur J Cancer ; 36(18): 2360-7, 2000 Dec.

Article in En | MEDLINE | ID: mdl-11094310

Subject(s)

Antigens, CD34; Hematopoietic Stem Cell Transplantation/methods; Lymphoma, Non-Hodgkin/therapy; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols/administration & dosage; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Blood Component Removal; Cost-Benefit Analysis; Cyclophosphamide/administration & dosage; Disease-Free Survival; Dose-Response Relationship, Immunologic; Doxorubicin/administration & dosage; Female; Graft Survival; Hematopoietic Stem Cell Mobilization/economics; Hematopoietic Stem Cell Mobilization/methods; Hematopoietic Stem Cell Transplantation/economics; Humans; Lymphoma, Non-Hodgkin/economics; Male; Middle Aged; Prednisone/administration & dosage; Vincristine/administration & dosage

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Non-Hodgkin / Hematopoietic Stem Cell Transplantation / Antigens, CD34 Type of study: Clinical_trials / Health_economic_evaluation Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Language: En Journal: Eur J Cancer Year: 2000 Type: Article Affiliation country: France

Search on Google

XML

PubMed Links